Literature DB >> 32246237

Transductal versus transcystic laparoscopic common bile duct exploration: an institutional review of over four hundred cases.

Lalin Navaratne1, Alberto Martinez Isla2.   

Abstract

BACKGROUND: Many studies have failed to demonstrate significant differences between single- and two-staged approaches for the management of choledocholithiasis with concomitant gallstones in terms of post-operative morbidity. However, none of these studies paid specific attention to the differences between the methods of accessing the bile duct during laparoscopy. The aim of this study was to report outcomes of transcystic versus transductal laparoscopic common bile duct exploration (LCBDE) from our experience of over four hundred cases.
METHODS: Retrospective review of 416 consecutive patients who underwent LCBDE at a single-centre between 1998 and 2018 was performed. Data collected included pre-operative demographic information, medical co-morbidity, pre-operative investigations, intra-operative findings (including negative choledochoscopy rates, use of holmium laser lithotripsy and operative time) and post-operative outcomes.
RESULTS: Transductal LCBDE via choledochotomy was achieved in 242 patients (58.2%), whereas 174 patients (41.8%) underwent transcystic LCBDE. Stone clearance rates, conversion to open surgery and mortality were similar between the two groups. Overall morbidity as well as minor and major post-operative complications were significantly higher in the transductal group. The main surgery-related complications were bile leak (5.8% vs 1.1%, p = 0.0181) and pancreatitis (7.4% vs 0.6%, p = 0.0005). Median length of post-operative stay was also significantly greater in the transductal group.
CONCLUSION: This study represents the largest single study to date comparing outcomes from transcystic and transductal LCBDE. Where possibly, the transcystic route should be used for LCBDE and this approach can be augmented with various techniques to increase successful stone clearance and reduce the need for choledochotomy.

Entities:  

Keywords:  Choledocholithiasis; Choledochotomy; Laparoscopic common bile duct exploration; Transcystic choledochoscopy; Transductal choledochoscopy

Mesh:

Year:  2020        PMID: 32246237     DOI: 10.1007/s00464-020-07522-7

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  2 in total

1.  10 years of laparoscopic common bile duct exploration: A single tertiary institution experience.

Authors:  L Navaratne; A Martinez-Isla
Journal:  Am J Surg       Date:  2019-04-19       Impact factor: 2.565

2.  Prospective randomized trial of LC+LCBDE vs ERCP/S+LC for common bile duct stone disease.

Authors:  Stanley J Rogers; John P Cello; Jan K Horn; Allan E Siperstein; William P Schecter; Andre R Campbell; Robert C Mackersie; Alex Rodas; Huub T C Kreuwel; Hobart W Harris
Journal:  Arch Surg       Date:  2010-01
  2 in total
  3 in total

1.  Primary duct closure versus T-tube drainage after laparoscopic common bile duct exploration: a meta-analysis.

Authors:  Taifeng Zhu; Haoming Lin; Jian Sun; Chao Liu; Rui Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2021-12-15       Impact factor: 3.066

2.  Medium and long-term complications difference between laparoscopic transcystic common bile duct exploration versus endoscopic sphincterotomy against choledocholithiasis: A protocol for systematic review and meta-analysis.

Authors:  Quanxin Liu; Tao Li; Zhangdong Feng; Wei Han
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

Review 3.  Comparison of intraoperative endoscopic retrograde cholangiopancreatography and laparoscopic common bile duct exploration combined with laparoscopic cholecystectomy for treating gallstones and common bile duct stones: a systematic review and meta-analysis.

Authors:  Caining Lei; Tingting Lu; Wenwen Yang; Man Yang; Hongwei Tian; Shaoming Song; Shiyi Gong; Jia Yang; Wenjie Jiang; Kehu Yang; Tiankang Guo
Journal:  Surg Endosc       Date:  2021-07-26       Impact factor: 4.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.